MetaADEDB 2.0 @ LMMD
clindamycin phosphate
(UFUVLHLTWXBHGZ-MGZQPHGTSA-N)
Structure
SMILES
CCC[C@H]1CN([C@@H](C1)C(=O)N[C@@H]([C@H]1O[C@H](SC)[C@@H]([C@H]([C@H]1O)O)OP(=O)(O)O)[C@@H](Cl)C)C
Molecular Formula:
C18H34ClN2O8PS
Molecular Weight:
504.963
Log P:
0.8353
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
5
TPSA:
183.9
CAS Number(s):
24729-96-2
Synonym(s)
1.
clindamycin phosphate
2.
Cleocin phosphate
3.
Clindesse
4.
Clindets
5.
clindamycin-2-phosphate
External Link(s)
MeSHC007084
PubChem Compound443385
BindingDB241975
CHEMBLCHEMBL3184512
DrugCentral3909
KEGGcpd:C11728
dr:D01073
ZINC4102185
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 41US FAERS
2Product quality issueFAERS: 18US FAERS
3ErythemaFAERS: 15US FAERS
4Burning sensationFAERS: 13US FAERS
5HypersensitivityFAERS: 12US FAERS
6PruritusFAERS: 11US FAERS
7Poor quality drug administeredFAERS: 10US FAERS
8Accidental exposure to productFAERS: 9US FAERS
9Vaginal DischargeFAERS: 9US FAERS
10Dry skinFAERS: 7US FAERS
11NauseaFAERS: 7US FAERS
12PainFAERS: 7US FAERS
13Acute kidney injuryFAERS: 6US FAERS
14Drug administration errorFAERS: 6US FAERS
15Eye painFAERS: 6US FAERS
16InfectionFAERS: 6OFFSIDES
US FAERS
17UrticariaFAERS: 6US FAERS
18Vulvovaginal burning sensationFAERS: 6US FAERS
19Abdominal PainFAERS: 5OFFSIDES
US FAERS
20AcneFAERS: 5OFFSIDES
US FAERS
21Incorrect dose administeredFAERS: 5US FAERS
22MalaiseFAERS: 5US FAERS
23Skin irritationFAERS: 5US FAERS
24Therapeutic response unexpectedFAERS: 5US FAERS
25TracheitisFAERS: 5US FAERS
26ChillsFAERS: 4US FAERS
27Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
28Drug ineffective for unapproved indicationFAERS: 4US FAERS
29Expired product administeredFAERS: 4US FAERS
30Foreign body aspirationFAERS: 4US FAERS
31Product container issueFAERS: 4US FAERS
32Skin tightnessFAERS: 4US FAERS
33Vulvovaginal pruritusFAERS: 4US FAERS
34Accidental overdoseFAERS: 3US FAERS
35Anaphylactic shockFAERS: 3US FAERS
36AngioedemaFAERS: 3OFFSIDES
US FAERS
37Application site painFAERS: 3US FAERS
38DehydrationFAERS: 3OFFSIDES
US FAERS
39Drug dispensing errorFAERS: 3US FAERS
40Drug exposure during pregnancyFAERS: 3US FAERS
41DysphoniaFAERS: 3US FAERS
42ExcoriationFAERS: 3US FAERS
43Product container seal issueFAERS: 3US FAERS
44Product leakageFAERS: 3US FAERS
45Product packaging issueFAERS: 3US FAERS
46Product packaging quantity issueFAERS: 3US FAERS
47Rash erythematousFAERS: 3US FAERS
48Subcutaneous AbscessFAERS: 3OFFSIDES
US FAERS
49SyncopeFAERS: 3US FAERS
50VomitingFAERS: 3US FAERS
51Vulvovaginal injuryFAERS: 3US FAERS
52Wrong technique in product usage processFAERS: 3US FAERS
53jaundiceFAERS: 3US FAERS
54Application site reactionFAERS: 2US FAERS
55AstheniaFAERS: 2US FAERS
56Cardiac ArrestFAERS: 2US FAERS
57Catheter related infectionFAERS: 2OFFSIDES
US FAERS
58Chest discomfortFAERS: 2US FAERS
59DizzinessFAERS: 2US FAERS
60Drug dose omissionFAERS: 2US FAERS
61Drug prescribing errorFAERS: 2US FAERS
62Dry gangreneFAERS: 2US FAERS
63DysgeusiaFAERS: 2US FAERS
64DyspepsiaFAERS: 2OFFSIDES
US FAERS
65Eye irritationFAERS: 2US FAERS
66HeadacheFAERS: 2US FAERS
67HepatotoxicityFAERS: 2US FAERS
68House dust allergyFAERS: 2US FAERS
69InflammationFAERS: 2US FAERS
70Intentional drug misuseFAERS: 2US FAERS
71Medication ErrorFAERS: 2US FAERS
72Muscle SpasticityFAERS: 2US FAERS
73No adverse eventFAERS: 2US FAERS
74OsteomyelitisFAERS: 2US FAERS
75Penile burning sensationFAERS: 2US FAERS
76Pre-existing condition improvedFAERS: 2US FAERS
77Product physical consistency issueFAERS: 2US FAERS
78Product taste abnormalFAERS: 2US FAERS
79Product use in unapproved indicationFAERS: 2US FAERS
80Reaction to drug excipientsFAERS: 2US FAERS
81Respiratory distressFAERS: 2US FAERS
82Septic ShockFAERS: 2OFFSIDES
US FAERS
83Skin UlcerFAERS: 2US FAERS
84Skin reactionFAERS: 2US FAERS
85Thermal burnFAERS: 2US FAERS
86TinnitusFAERS: 2US FAERS
87Toxic Epidermal NecrolysisFAERS: 2US FAERS
88Urinary tract infectionFAERS: 2US FAERS
89Weight decreasedFAERS: 2US FAERS
90WheezingFAERS: 2US FAERS
91Abdominal discomfortFAERS: 1OFFSIDES
US FAERS
92AbscessFAERS: 1US FAERS
93AcarodermatitisFAERS: 1US FAERS
94Accidental exposureFAERS: 1US FAERS
95AcidosisFAERS: 1OFFSIDES
US FAERS
96Activities of daily living impairedFAERS: 1US FAERS
97Alanine Aminotransferase IncreasedFAERS: 1OFFSIDES
US FAERS
98AlopeciaFAERS: 1US FAERS
99Anal FissureFAERS: 1OFFSIDES
US FAERS
100Antiacetylcholine receptor antibody positiveFAERS: 1US FAERS
101Antibiotic level below therapeuticFAERS: 1US FAERS
102Antibody test positiveFAERS: 1US FAERS
103Application site burnFAERS: 1US FAERS
104Application site drynessFAERS: 1US FAERS
105Application site erythemaFAERS: 1US FAERS
106Application site irritationFAERS: 1US FAERS
107Application site pruritusFAERS: 1US FAERS
108Application site rashFAERS: 1US FAERS
109Application site scarFAERS: 1US FAERS
110ArthritisFAERS: 1US FAERS
111ArthropathyFAERS: 1US FAERS
112Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
113Atrioventricular Septal DefectFAERS: 1US FAERS
114BedriddenFAERS: 1US FAERS
115Blood creatinine increasedFAERS: 1OFFSIDES
US FAERS
116Blood iron decreasedFAERS: 1US FAERS
117Borrelia burgdorferi serology positiveFAERS: 1US FAERS
118BronchitisFAERS: 1US FAERS
119BruxismFAERS: 1US FAERS
120Capsule physical issueFAERS: 1US FAERS
121Catheter site painFAERS: 1US FAERS
122Central line infectionFAERS: 1US FAERS
123ChokingFAERS: 1OFFSIDES
US FAERS
124ChromaturiaFAERS: 1US FAERS
125Clostridium difficile infectionFAERS: 1US FAERS
126Clostridium test positiveFAERS: 1US FAERS
127ConjunctivitisFAERS: 1US FAERS
128ConstipationFAERS: 1US FAERS
129CyanosisFAERS: 1US FAERS
130Deafness NeurosensoryFAERS: 1US FAERS
131DeafnessFAERS: 1OFFSIDES
US FAERS
132Device breakageFAERS: 1US FAERS
133Disease ProgressionFAERS: 1US FAERS
134DroolingFAERS: 1US FAERS
135Drug effect incompleteFAERS: 1US FAERS
136Drug level below therapeuticFAERS: 1US FAERS
137Drug resistanceFAERS: 1US FAERS
138DysarthriaFAERS: 1US FAERS
139Economic problemFAERS: 1US FAERS
140EczemaFAERS: 1US FAERS
141Educational problemFAERS: 1US FAERS
142Emotional disorderFAERS: 1US FAERS
143EnterocolitisFAERS: 1US FAERS
144ExophthalmosFAERS: 1US FAERS
145Exposure via eye contactFAERS: 1US FAERS
146Exposure via partnerFAERS: 1US FAERS
147ExtravasationFAERS: 1US FAERS
148Facial PainFAERS: 1US FAERS
149FatigueFAERS: 1OFFSIDES
US FAERS
150Feeling abnormalFAERS: 1US FAERS
151Feeling jitteryFAERS: 1US FAERS
152FolliculitisFAERS: 1OFFSIDES
US FAERS
153Foreign body traumaFAERS: 1US FAERS
154GastroenteritisFAERS: 1US FAERS
155Gastrointestinal PainFAERS: 1US FAERS
156Gastrointestinal ulcerFAERS: 1US FAERS
157General physical condition abnormalFAERS: 1US FAERS
158Genital injuryFAERS: 1US FAERS
159HypertrichosisFAERS: 1US FAERS
160HypophagiaFAERS: 1US FAERS
161Impaired work abilityFAERS: 1US FAERS
162Inappropriate schedule of drug administrationFAERS: 1US FAERS
163Inappropriate schedule of product administrationFAERS: 1US FAERS
164Incorrect dose administered by deviceFAERS: 1US FAERS
165Incorrect drug administration durationFAERS: 1US FAERS
166Incorrect route of drug administrationFAERS: 1US FAERS
167Increased upper airway secretionFAERS: 1US FAERS
168Infantile apnoeic attackFAERS: 1US FAERS
169Intestinal congestionFAERS: 1US FAERS
170Irritable Bowel SyndromeFAERS: 1US FAERS
171Kounis SyndromeFAERS: 1US FAERS
172Laryngeal ObstructionFAERS: 1US FAERS
173Limb injuryFAERS: 1US FAERS
174Local reactionFAERS: 1US FAERS
175MalabsorptionFAERS: 1US FAERS
176MalnutritionFAERS: 1US FAERS
177Maternal exposure during breast feedingFAERS: 1US FAERS
178MetrorrhagiaFAERS: 1US FAERS
179Myasthenic SyndromeFAERS: 1OFFSIDES
US FAERS
180NecrosisFAERS: 1US FAERS
181Nerve injuryFAERS: 1US FAERS
182NocturiaFAERS: 1US FAERS
183Open woundFAERS: 1US FAERS
184OphthalmoplegiaFAERS: 1US FAERS
185Oropharyngeal cancer stage unspecifiedFAERS: 1US FAERS
186Oropharyngeal plaqueFAERS: 1US FAERS
187PancytopeniaFAERS: 1US FAERS
188Pathogen resistanceFAERS: 1US FAERS
189Pericardial effusionFAERS: 1OFFSIDES
US FAERS
190Peripheral swellingFAERS: 1US FAERS
191Pharmaceutical product complaintFAERS: 1US FAERS
192Positron emission tomogram abnormalFAERS: 1US FAERS
193Post procedural complicationFAERS: 1OFFSIDES
US FAERS
194Postoperative wound complicationFAERS: 1US FAERS
195Product dispensing errorFAERS: 1US FAERS
196Product dosage form issueFAERS: 1US FAERS
197Product formulation issueFAERS: 1US FAERS
198Product physical issueFAERS: 1US FAERS
199Product preparation errorFAERS: 1US FAERS
200Product solubility abnormalFAERS: 1US FAERS
201Product substitution issueFAERS: 1US FAERS
202Refusal of treatment by relativeFAERS: 1US FAERS
203Renal tubular disorderFAERS: 1US FAERS
204Respiratory FailureFAERS: 1US FAERS
205Respiratory arrestFAERS: 1US FAERS
206RetchingFAERS: 1US FAERS
207Secretion dischargeFAERS: 1US FAERS
208Skin PapillomaFAERS: 1US FAERS
209Skin necrosisFAERS: 1US FAERS
210Sperm count decreasedFAERS: 1US FAERS
211StomatitisFAERS: 1US FAERS
212SwellingFAERS: 1US FAERS
213Therapy cessationFAERS: 1US FAERS
214ThirstFAERS: 1US FAERS
215Throat irritationFAERS: 1US FAERS
216ThrombocytopeniaFAERS: 1US FAERS
217ThrombophlebitisFAERS: 1US FAERS
218ThrombosisFAERS: 1US FAERS
219TremorFAERS: 1US FAERS
220TrismusFAERS: 1US FAERS
221Unevaluable eventFAERS: 1US FAERS
222Upper respiratory tract congestionFAERS: 1US FAERS
223Varicella zoster virus serology positiveFAERS: 1US FAERS
224VasculitisFAERS: 1US FAERS
225Visual disturbanceFAERS: 1OFFSIDES
US FAERS
226Vulvovaginal discomfortFAERS: 1US FAERS
227Vulvovaginal mycotic infectionFAERS: 1OFFSIDES
US FAERS
228Vulvovaginal swellingFAERS: 1US FAERS
229Wound necrosisFAERS: 1US FAERS
230Wrong technique in drug usage processFAERS: 1US FAERS
231ZygomycosisFAERS: 1US FAERS
232furuncleFAERS: 1OFFSIDES
US FAERS
233Abdominal strangulated herniaOFFSIDES
234Abdominal tendernessOFFSIDES
235Acute bronchitisOFFSIDES
236Anal FistulaOFFSIDES
237AnorexiaOFFSIDES
238AnoxiaOFFSIDES
239Antidepressant drug clearance decreasedOFFSIDES
240Aphthous StomatitisOFFSIDES
241ArteriosclerosisOFFSIDES
242AtherosclerosisOFFSIDES
243AutomatismOFFSIDES
244Bacteroides Infections4609237CTD
245BasophiliaOFFSIDES
246Blood alkaline phosphatase increasedOFFSIDES
247Blood bilirubin unconjugated increasedOFFSIDES
248Blood lactate dehydrogenase increasedOFFSIDES
249Blood potassium increasedOFFSIDES
250Blood pressure immeasurableOFFSIDES
251Blood sodium increasedOFFSIDES
252Blood urine presentOFFSIDES
253Brain natriuretic peptide increasedOFFSIDES
254Cardiac TamponadeOFFSIDES
255Cardiovascular insufficiencyOFFSIDES
256Central Nervous System InfectionOFFSIDES
257Chest PainOFFSIDES
258CholangiolitisOFFSIDES
259Chronic ulcerative colitisOFFSIDES
260Clostridium difficile colitisOFFSIDES
261Colon adenomaOFFSIDES
262Colonic StenosisOFFSIDES
263Culture positiveOFFSIDES
264Depressed Level of ConsciousnessOFFSIDES
265DiarrheaOFFSIDES
266Disseminated Intravascular CoagulationOFFSIDES
267EndocarditisOFFSIDES
268Engraft failureOFFSIDES
269Epidural AbscessOFFSIDES
270EpiglottitisOFFSIDES
271EpilepsyOFFSIDES
272EpiscleritisOFFSIDES
273Erosive gastritisOFFSIDES
274Facial NeuralgiaOFFSIDES
275Febrile NeutropeniaOFFSIDES
276Feeling ColdOFFSIDES
277Flank PainOFFSIDES
278Gastrointestinal mucosal disorderOFFSIDES
279General physical health deteriorationOFFSIDES
280Genital dischargeOFFSIDES
281GoiterOFFSIDES
282Graft dysfunctionOFFSIDES
283GranulocytosisOFFSIDES
284HyperventilationOFFSIDES
285HypoxiaOFFSIDES
286IleitisOFFSIDES
287Immunosuppressant drug levelOFFSIDES
288ImpetigoOFFSIDES
289Implant site erosionOFFSIDES
290Intestinal ObstructionOFFSIDES
291Kidney NeoplasmOFFSIDES
292Leukopenia neonatalOFFSIDES
293Lymphocyte stimulation test positiveOFFSIDES
294Malignant neoplasm progressionOFFSIDES
295Multi-organ disorderOFFSIDES
296Occult blood positiveOFFSIDES
297Perirectal abscessOFFSIDES
298PhlebitisOFFSIDES
299Post inflammatory pigmentation changeOFFSIDES
300Postrenal failureOFFSIDES
301Procedural complicationOFFSIDES
302ProctitisOFFSIDES
303Puncture site painOFFSIDES
304Reperfusion InjuryOFFSIDES
305Sepsis448989CTD
306Skin test positiveOFFSIDES
307Sputum culture positiveOFFSIDES
308Staphylococcal Infections448989CTD
309Stevens-Johnson SyndromeOFFSIDES
310Stress at workOFFSIDES
311Superficial ThrombophlebitisOFFSIDES
312Tachycardia, Paroxysmal7089634CTD
313Therapy non-responderOFFSIDES
314Transfusion ReactionOFFSIDES
315Trichosporon infectionOFFSIDES
316Uterine PolypOFFSIDES
317Ventricular FibrillationOFFSIDES
318Weight GainOFFSIDES
319Wound infection pseudomonasOFFSIDES
320Wound infection staphylococcalOFFSIDES
321carbuncleOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.